FDA Warning Letter Urges St. Gobain To Get Hip To QSR Regs
This article was originally published in The Gray Sheet
Executive Summary
Saint Gobain Advanced Ceramics Desmarquest did not adaquately verify and validate changes it made to its manufacturing process in 1998, FDA asserts in a recent warning letter outlining quality system reg (QSR) deficiencies related to certain artificial hip components